Gastrointestinal Manifestations Among Patients With COVID19
NCT ID: NCT04544150
Last Updated: 2020-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
220 participants
OBSERVATIONAL
2020-06-01
2020-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gastrointestinal Symptoms in COVID-19
NCT04691895
The Impact of COVID-19 Infection on the Symptoms of Functional Dyspepsia
NCT05749692
Post Covid Syndrome: Clinical Pattern and Functional Assessment
NCT04561141
Identification of Entamoeba Spp. in Assuit Governorate Hospitals.
NCT04466449
Helicobacter Pylori Gastritis and Its Relation to Metabolic Syndrome Components
NCT06935955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohammed Abu Elfatth
Al-rahji University Hospital, Faculty of Medicine, Assiut, Egypt
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Abu elfatth
Role: PRINCIPAL_INVESTIGATOR
Assuit University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ahmed
Al Minyā, Alminya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Peck-Radosavljevic M, Danese S, Hartmann D, Saftoiu A, Van Hootegem P; UEG Public Affairs Committee. COVID-19 and digestive health. United European Gastroenterol J. 2020 Jun;8(5):624-626. doi: 10.1177/2050640620927955. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID19 and GUT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.